table of content
1 Introduction to Research & Analysis Reports
1.1 Tumor Genomics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tumor Genomics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tumor Genomics Overall Market Size
2.1 Global Tumor Genomics Market Size: 2023 VS 2030
2.2 Global Tumor Genomics Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tumor Genomics Players in Global Market
3.2 Top Global Tumor Genomics Companies Ranked by Revenue
3.3 Global Tumor Genomics Revenue by Companies
3.4 Top 3 and Top 5 Tumor Genomics Companies in Global Market, by Revenue in 2023
3.5 Global Companies Tumor Genomics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tumor Genomics Players in Global Market
3.6.1 List of Global Tier 1 Tumor Genomics Companies
3.6.2 List of Global Tier 2 and Tier 3 Tumor Genomics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Tumor Genomics Market Size Markets, 2023 & 2030
4.1.2 Assays and Kits
4.1.3 Instrument
4.2 By Type - Global Tumor Genomics Revenue & Forecasts
4.2.1 By Type - Global Tumor Genomics Revenue, 2019-2024
4.2.2 By Type - Global Tumor Genomics Revenue, 2025-2030
4.2.3 By Type - Global Tumor Genomics Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tumor Genomics Market Size, 2023 & 2030
5.1.2 Diagnostics and Monitoring
5.1.3 Drug Discovery and Development
5.1.4 Biomarker Discovery
5.2 By Application - Global Tumor Genomics Revenue & Forecasts
5.2.1 By Application - Global Tumor Genomics Revenue, 2019-2024
5.2.2 By Application - Global Tumor Genomics Revenue, 2025-2030
5.2.3 By Application - Global Tumor Genomics Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Tumor Genomics Market Size, 2023 & 2030
6.2 By Region - Global Tumor Genomics Revenue & Forecasts
6.2.1 By Region - Global Tumor Genomics Revenue, 2019-2024
6.2.2 By Region - Global Tumor Genomics Revenue, 2025-2030
6.2.3 By Region - Global Tumor Genomics Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Tumor Genomics Revenue, 2019-2030
6.3.2 US Tumor Genomics Market Size, 2019-2030
6.3.3 Canada Tumor Genomics Market Size, 2019-2030
6.3.4 Mexico Tumor Genomics Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Tumor Genomics Revenue, 2019-2030
6.4.2 Germany Tumor Genomics Market Size, 2019-2030
6.4.3 France Tumor Genomics Market Size, 2019-2030
6.4.4 U.K. Tumor Genomics Market Size, 2019-2030
6.4.5 Italy Tumor Genomics Market Size, 2019-2030
6.4.6 Russia Tumor Genomics Market Size, 2019-2030
6.4.7 Nordic Countries Tumor Genomics Market Size, 2019-2030
6.4.8 Benelux Tumor Genomics Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Tumor Genomics Revenue, 2019-2030
6.5.2 China Tumor Genomics Market Size, 2019-2030
6.5.3 Japan Tumor Genomics Market Size, 2019-2030
6.5.4 South Korea Tumor Genomics Market Size, 2019-2030
6.5.5 Southeast Asia Tumor Genomics Market Size, 2019-2030
6.5.6 India Tumor Genomics Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Tumor Genomics Revenue, 2019-2030
6.6.2 Brazil Tumor Genomics Market Size, 2019-2030
6.6.3 Argentina Tumor Genomics Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tumor Genomics Revenue, 2019-2030
6.7.2 Turkey Tumor Genomics Market Size, 2019-2030
6.7.3 Israel Tumor Genomics Market Size, 2019-2030
6.7.4 Saudi Arabia Tumor Genomics Market Size, 2019-2030
6.7.5 UAE Tumor Genomics Market Size, 2019-2030
7 Tumor Genomics Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Tumor Genomics Major Product Offerings
7.1.4 Abbott Laboratories Tumor Genomics Revenue in Global Market (2019-2024)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Agilent Technologies, Inc
7.2.1 Agilent Technologies, Inc Company Summary
7.2.2 Agilent Technologies, Inc Business Overview
7.2.3 Agilent Technologies, Inc Tumor Genomics Major Product Offerings
7.2.4 Agilent Technologies, Inc Tumor Genomics Revenue in Global Market (2019-2024)
7.2.5 Agilent Technologies, Inc Key News & Latest Developments
7.3 Bio-Rad Laboratories, Inc.
7.3.1 Bio-Rad Laboratories, Inc. Company Summary
7.3.2 Bio-Rad Laboratories, Inc. Business Overview
7.3.3 Bio-Rad Laboratories, Inc. Tumor Genomics Major Product Offerings
7.3.4 Bio-Rad Laboratories, Inc. Tumor Genomics Revenue in Global Market (2019-2024)
7.3.5 Bio-Rad Laboratories, Inc. Key News & Latest Developments
7.4 Danaher Corporation
7.4.1 Danaher Corporation Company Summary
7.4.2 Danaher Corporation Business Overview
7.4.3 Danaher Corporation Tumor Genomics Major Product Offerings
7.4.4 Danaher Corporation Tumor Genomics Revenue in Global Market (2019-2024)
7.4.5 Danaher Corporation Key News & Latest Developments
7.5 F. Hoffmann-La Roche Ltd
7.5.1 F. Hoffmann-La Roche Ltd Company Summary
7.5.2 F. Hoffmann-La Roche Ltd Business Overview
7.5.3 F. Hoffmann-La Roche Ltd Tumor Genomics Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd Tumor Genomics Revenue in Global Market (2019-2024)
7.5.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.6 Fluidigm Corporation
7.6.1 Fluidigm Corporation Company Summary
7.6.2 Fluidigm Corporation Business Overview
7.6.3 Fluidigm Corporation Tumor Genomics Major Product Offerings
7.6.4 Fluidigm Corporation Tumor Genomics Revenue in Global Market (2019-2024)
7.6.5 Fluidigm Corporation Key News & Latest Developments
7.7 General Electric Company
7.7.1 General Electric Company Company Summary
7.7.2 General Electric Company Business Overview
7.7.3 General Electric Company Tumor Genomics Major Product Offerings
7.7.4 General Electric Company Tumor Genomics Revenue in Global Market (2019-2024)
7.7.5 General Electric Company Key News & Latest Developments
7.8 Illumina, Inc.
7.8.1 Illumina, Inc. Company Summary
7.8.2 Illumina, Inc. Business Overview
7.8.3 Illumina, Inc. Tumor Genomics Major Product Offerings
7.8.4 Illumina, Inc. Tumor Genomics Revenue in Global Market (2019-2024)
7.8.5 Illumina, Inc. Key News & Latest Developments
7.9 Merck KGaA
7.9.1 Merck KGaA Company Summary
7.9.2 Merck KGaA Business Overview
7.9.3 Merck KGaA Tumor Genomics Major Product Offerings
7.9.4 Merck KGaA Tumor Genomics Revenue in Global Market (2019-2024)
7.9.5 Merck KGaA Key News & Latest Developments
7.10 Myriad Genetics, Inc.
7.10.1 Myriad Genetics, Inc. Company Summary
7.10.2 Myriad Genetics, Inc. Business Overview
7.10.3 Myriad Genetics, Inc. Tumor Genomics Major Product Offerings
7.10.4 Myriad Genetics, Inc. Tumor Genomics Revenue in Global Market (2019-2024)
7.10.5 Myriad Genetics, Inc. Key News & Latest Developments
7.11 Pacific Biosciences of California, Inc.
7.11.1 Pacific Biosciences of California, Inc. Company Summary
7.11.2 Pacific Biosciences of California, Inc. Business Overview
7.11.3 Pacific Biosciences of California, Inc. Tumor Genomics Major Product Offerings
7.11.4 Pacific Biosciences of California, Inc. Tumor Genomics Revenue in Global Market (2019-2024)
7.11.5 Pacific Biosciences of California, Inc. Key News & Latest Developments
7.12 PerkinElmer
7.12.1 PerkinElmer Company Summary
7.12.2 PerkinElmer Business Overview
7.12.3 PerkinElmer Tumor Genomics Major Product Offerings
7.12.4 PerkinElmer Tumor Genomics Revenue in Global Market (2019-2024)
7.12.5 PerkinElmer Key News & Latest Developments
7.13 QIAGEN
7.13.1 QIAGEN Company Summary
7.13.2 QIAGEN Business Overview
7.13.3 QIAGEN Tumor Genomics Major Product Offerings
7.13.4 QIAGEN Tumor Genomics Revenue in Global Market (2019-2024)
7.13.5 QIAGEN Key News & Latest Developments
7.14 Siemens Healthineers AG
7.14.1 Siemens Healthineers AG Company Summary
7.14.2 Siemens Healthineers AG Business Overview
7.14.3 Siemens Healthineers AG Tumor Genomics Major Product Offerings
7.14.4 Siemens Healthineers AG Tumor Genomics Revenue in Global Market (2019-2024)
7.14.5 Siemens Healthineers AG Key News & Latest Developments
7.15 Thermo Fisher Scientific Inc.
7.15.1 Thermo Fisher Scientific Inc. Company Summary
7.15.2 Thermo Fisher Scientific Inc. Business Overview
7.15.3 Thermo Fisher Scientific Inc. Tumor Genomics Major Product Offerings
7.15.4 Thermo Fisher Scientific Inc. Tumor Genomics Revenue in Global Market (2019-2024)
7.15.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
